MedPath

Comparative Analysis of Remimazolam and Propofol on Cerebral Oxygenation during Laminectomy (RCT effect of REMIPRO on Cerebral Oxygenation)

Not yet recruiting
Conditions
spinal disease requiring laminectomy
Registration Number
jRCT1032250023
Lead Sponsor
None
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
10
Inclusion Criteria

Eligibility Criteria for Elderly Participants (70 years or older):

Diagnosis: Presence of spinal diseases requiring single or double-level laminectomy of the thoracic and/or lumbar spine. ASA Classification: Patients classified as ASA I-III (including relatively healthy patients and those with mild to moderate systemic diseases). BMI: BMI between 18.5 and less than 30. Position Tolerance: Ability to tolerate the prone position. Informed Consent: Ability to fully understand the research plan and provide informed consent independently. Operating Table: Spinal surgery using a surgical table such as Mizuno OSI Trios or Mizuno MOT-8300, with a pillow designed for the prone position.

Exclusion Criteria
  1. Uncontrolled cardiovascular diseases (e.g., heart failure, severe arrhythmias)
  2. Severe respiratory diseases (e.g., chronic obstructive pulmonary disease, high-risk obstructive sleep apnea syndrome [vital capacity <60%, 1-second volume <50%])
  3. Severe liver dysfunction (e.g., Child-Pugh classification C)
  4. Severe neurological diseases (evaluated by mini-cog test)
  5. Coagulation disorders (e.g., platelet count <80,000, PT-INR >1.5, or APTT >40 seconds)
  6. Uncontrolled diabetes or other metabolic disorders affecting anesthetic response
  7. History of allergies to remimazolam, propofol, benzodiazepines, or soy/egg-based products
  8. Closed-angle glaucoma
  9. Emergency surgery 10.Surgical procedures requiring complex operations other than laminectomy
  10. Spinal surgery requiring head fixation with a 3-point fixation system
  11. Anesthesia history within the past 30 days
  12. Refusal to participate in the study

Study & Design

Study Type
Interventional
Study Design
parallel assignment
Primary Outcome Measures
NameTimeMethod
-

mean rScO2 measured by NIRS at different time points throughout the procedure

Secondary Outcome Measures
NameTimeMethod
Changes in hemodynamic parametersover time

MAP, HR, CO, PaO2, paCO2

Incidence of intraoperative complications

hypo/hypertension, brady/tachycardia, hypoxemia

Impact of prone positioning on cerebral oxygenation and hemodynamicsbefore versus after prone positioning

changes in rScO2, MAP, PaO2, PaCO2, and CO

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.